Société XSPY PHAR Nasdaq Stockholm
Actions
SE0009973563
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Per Andersson
CEO | Chief Executive Officer | 57 | 01/09/06 |
Director of Finance/CFO | 52 | 08/02 | |
Thomas Walz
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/22 |
Chief Tech/Sci/R&D Officer | 60 | 01/01/18 | |
Investor Relations Contact | 63 | 15/05/19 | |
Sales & Marketing | - | 15/03/22 | |
Andreas Konar
PRN | Corporate Officer/Principal | 75 | 01/01/10 |
Edward Jordan
PRN | Corporate Officer/Principal | 55 | 15/09/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 71 | 01/01/15 | |
Carl-Johan Spak
BRD | Director/Board Member | 68 | 01/01/15 |
Chairman | 70 | 19/05/22 | |
Director/Board Member | 55 | 01/01/17 | |
Christine Lind
BRD | Director/Board Member | 50 | 01/01/19 |
Director/Board Member | 66 | 01/01/21 | |
Robert Molander
BRD | Director/Board Member | 59 | 19/05/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 31 253 542 | 16 001 596 ( 51,20 %) | 0 | 51,20 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+9,42% | 115 Md | |
+11,84% | 106 Md | |
-1,05% | 21,96 Md | |
-14,15% | 21,84 Md | |
-5,29% | 19,21 Md | |
-4,16% | 18,08 Md | |
-38,29% | 17,71 Md | |
+7,99% | 14,32 Md | |
+36,24% | 12,42 Md |